New Tool Helps Doctors Predict Statin Side Effects Before Prescribing

A new tool has been developed to help doctors predict which patients may experience side effects from statins. The medication can significantly lower cholesterol but is underused, with fewer than half of eligible Americans taking it. Many stop treatment early due to concerns over possible risks. Statins are known to reduce LDL cholesterol by up to 60%, cutting the risk of heart attacks and strokes. Yet around 40% of those prescribed the drug stop using it within three months. Some of this hesitation stems from misinformation and exaggerated fears about side effects.

Clinical trials show that mild muscle pain is slightly more common in statin users than in those taking a placebo. However, serious muscle disorders like myalgia or rhabdomyolysis are rare, affecting only a tiny fraction of users. The new tool helps doctors distinguish between mild and severe symptoms.

It also identifies patients at higher risk, such as those with kidney disease or on certain medications. Doctors can then adjust doses or switch to alternative treatments to minimise side effects. The tool aims to improve statin use by providing clearer risk assessments. With better information, doctors can tailor treatments more effectively. This could help more people benefit from the drug’s protective effects against heart disease.